<?xml version="1.0" ?>
<tei>
	<teiHeader>
		<fileDesc xml:id="55009360"/>
	</teiHeader>
	<text xml:lang="en">
		<front>
<lb/>
	<note type="other">Home<lb/> Meeting Index<lb/> Search<lb/> ACR Homepage<lb/> Arthritis &amp; Rheumatism Issues<lb/> Privacy Policy<lb/> </note>

	<docTitle>
	<titlePart>Arthritis &amp; Rheumatism, Volume 62,<lb/> November 2010 Abstract Supplement<lb/> </titlePart>
	</docTitle>
 
	<note type="other">Abstracts of the American College of<lb/> Rheumatology/Association of Rheumatology Health Professionals<lb/> Annual Scientific Meeting<lb/> </note>

	<address>Atlanta, Georgia </address>

	<date>November 6-11, 2010.<lb/></date>

	<docTitle>
	<titlePart>Proof Of Concept Study For A Potent P38 MAPK Dual Action Inhibitor<lb/> BMS-582949 In Subjects With RA Receiving Concomitant Methotrexate.<lb/></titlePart>
	</docTitle>
	
	<byline>
	<docAuthor>Genovese 6 , Mark C., Gao 3 , Ling, Yin 3 , Jie, Smith 3 , Stefani, Weinblatt 1 ,<lb/> Michael E., Smolen 5 , Josef S., Wang 3 , Xiaoning<lb/></docAuthor>
	</byline>

	<byline>
	<affiliation>Brigham &amp; Womens Hospital,</affiliation>
	</byline>

	<address>Boston, MA<lb/></address>

	<byline>
	<affiliation>Bristol-Myers Squibb,</affiliation>
	</byline>

	<address>Wayne, PA<lb/></address>

	<byline>
	<affiliation>Bristol-Myers Squibb<lb/> Hospital Cl√≠nico Universitario de Santiago,</affiliation>
	</byline>

	<address>Santiago de Compostela,<lb/> Spain</address>

	<byline>
	<affiliation>Krankenhaus Lainz,</affiliation>
	</byline>

	<address>Vienna, Austria<lb/></address>

	<byline>
	<affiliation>Stanford University,</affiliation>
	</byline>

	<address>Sunnyvale, CA<lb/></address>

	<note type="other">Background/Purpose:</note>

		</front>
	</text>
</tei>
